Skip to main content
. 2023 Jul 12;15(14):3589. doi: 10.3390/cancers15143589

Figure 1.

Figure 1

Currently proposed mechanisms of resistance to venetoclax in AML (increasing venetoclax resistance is demonstrated moving from left to right of the figure). Mechanisms associated with resistance to venetoclax include primary or secondary acquisition of molecularly defined resistant subclones, myeloid maturation state, and increased levels of alternative anti-apoptotic proteins, including BCL2L1 and MCL1, with respect to BCL-2 levels.